These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 20876116)

  • 1. O-linked β-N-acetylglucosamine transferase is indispensable in the failing heart.
    Watson LJ; Facundo HT; Ngoh GA; Ameen M; Brainard RE; Lemma KM; Long BW; Prabhu SD; Xuan YT; Jones SP
    Proc Natl Acad Sci U S A; 2010 Oct; 107(41):17797-802. PubMed ID: 20876116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte Ogt is essential for postnatal viability.
    Watson LJ; Long BW; DeMartino AM; Brittian KR; Readnower RD; Brainard RE; Cummins TD; Annamalai L; Hill BG; Jones SP
    Am J Physiol Heart Circ Physiol; 2014 Jan; 306(1):H142-53. PubMed ID: 24186210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive
    Umapathi P; Mesubi OO; Banerjee PS; Abrol N; Wang Q; Luczak ED; Wu Y; Granger JM; Wei AC; Reyes Gaido OE; Florea L; Talbot CC; Hart GW; Zachara NE; Anderson ME
    Circulation; 2021 Apr; 143(17):1687-1703. PubMed ID: 33593071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmented O-GlcNAcylation attenuates intermittent hypoxia-induced cardiac remodeling through the suppression of NFAT and NF-κB activities in mice.
    Nakagawa T; Furukawa Y; Hayashi T; Nomura A; Yokoe S; Moriwaki K; Kato R; Ijiri Y; Yamaguchi T; Izumi Y; Yoshiyama M; Asahi M
    Hypertens Res; 2019 Dec; 42(12):1858-1871. PubMed ID: 31409917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
    Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
    Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.
    Ida S; Morino K; Sekine O; Ohashi N; Kume S; Chano T; Iwasaki K; Harada N; Inagaki N; Ugi S; Maegawa H
    Diabetologia; 2017 Sep; 60(9):1761-1769. PubMed ID: 28642969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiomyocyte Ogt limits ventricular dysfunction in mice following pressure overload without affecting hypertrophy.
    Dassanayaka S; Brainard RE; Watson LJ; Long BW; Brittian KR; DeMartino AM; Aird AL; Gumpert AM; Audam TN; Kilfoil PJ; Muthusamy S; Hamid T; Prabhu SD; Jones SP
    Basic Res Cardiol; 2017 May; 112(3):23. PubMed ID: 28299467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc Transferase Promotes Compensated Cardiac Function and Protein Kinase A O-GlcNAcylation During Early and Established Pathological Hypertrophy From Pressure Overload.
    Zhu WZ; El-Nachef D; Yang X; Ledee D; Olson AK
    J Am Heart Assoc; 2019 Jun; 8(11):e011260. PubMed ID: 31131693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
    Dassanayaka S; Brittian KR; Long BW; Higgins LA; Bradley JA; Audam TN; Jurkovic A; Gumpert AM; Harrison LT; Hartyánszky I; Perge P; Merkely B; Radovits T; Hanover JA; Jones SP
    PLoS One; 2020; 15(11):e0242250. PubMed ID: 33253217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
    Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
    Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotective O-GlcNAc signaling is elevated in murine female hearts via enhanced O-GlcNAc transferase activity.
    Narayanan B; Sinha P; Henry R; Reeves RA; Paolocci N; Kohr MJ; Zachara NE
    J Biol Chem; 2023 Dec; 299(12):105447. PubMed ID: 37949223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-linked N-acetylglucosamine transferase (OGT) regulates pancreatic α-cell function in mice.
    Essawy A; Jo S; Beetch M; Lockridge A; Gustafson E; Alejandro EU
    J Biol Chem; 2021; 296():100297. PubMed ID: 33460647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of O-GlcNAc Levels in the Liver Impacts Acetaminophen-Induced Liver Injury by Affecting Protein Adduct Formation and Glutathione Synthesis.
    McGreal SR; Bhushan B; Walesky C; McGill MR; Lebofsky M; Kandel SE; Winefield RD; Jaeschke H; Zachara NE; Zhang Z; Tan EP; Slawson C; Apte U
    Toxicol Sci; 2018 Apr; 162(2):599-610. PubMed ID: 29325178
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Matsuno M; Yokoe S; Nagatsuka T; Morihara H; Moriwaki K; Asahi M
    Front Endocrinol (Lausanne); 2023; 14():1122125. PubMed ID: 37033243
    [No Abstract]   [Full Text] [Related]  

  • 17. O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.
    Ono S; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Chin-Kanasaki M; Araki H; Sekine O; Yokoi H; Mukoyama M; Uzu T; Araki SI; Maegawa H
    Nephrol Dial Transplant; 2017 Sep; 32(9):1477-1487. PubMed ID: 28339907
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Nakamoto A; Ohashi N; Sugawara L; Morino K; Ida S; Perry RJ; Sakuma I; Yanagimachi T; Fujita Y; Ugi S; Kume S; Shulman GI; Maegawa H
    Am J Physiol Endocrinol Metab; 2023 Jul; 325(1):E46-E61. PubMed ID: 37224467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition.
    Ngoh GA; Watson LJ; Facundo HT; Dillmann W; Jones SP
    J Mol Cell Cardiol; 2008 Aug; 45(2):313-25. PubMed ID: 18539296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of O-GlcNAc transferase in regulating the gene transcription of developing and failing hearts.
    Medford HM; Marsh SA
    Future Cardiol; 2014 Nov; 10(6):801-12. PubMed ID: 25495821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.